Price$183.99-17.93 (-8.88%)
2026-03-052026-06-08
News · 26 weeks107-30%
2025-12-142026-06-07
Mix4690d
- Insider17(37%)
- Other13(28%)
- SEC Filings9(20%)
- Analyst4(9%)
- Earnings2(4%)
- Dividends1(2%)
Latest news
25 items- SECDanaher Corporation filed SEC Form 8-K: Other Events8-K - DANAHER CORP /DE/ (0000313616) (Filer)
- ANALYSTDZ Bank initiated coverage on Danaher with a new price targetDZ Bank initiated coverage of Danaher with a rating of Buy and set a new price target of $210.00
- ANALYSTWolfe Research resumed coverage on DanaherWolfe Research resumed coverage of Danaher with a rating of Peer Perform
- PRSCIEX Launches the novus V55 System With SCIEX OS 5.0 Software and AI Enablement ToolsAt ASMS, SCIEX, a Danaher company and leader in life science analytical technologies, launched the novus V55 system - a next-generation triple quadrupole mass spectrometer designed for the realities of high-pressure, results-driven labs. The system provides exceptional sensitivity and accelerated output, in a smaller footprint and with improved energy efficiency when compared to the SCIEX 5500+ system. This quantitative solution expands testing capabilities across pesticide and food analysis, pharmaceutical impurities, bioanalysis, PFAS testing and additional applications. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260601916
- PRSCIEX Advances the ZenoTOF Line With Platform-Wide Expansions in Software, Integrations, and Key CollaborationsAt ASMS, SCIEX, a Danaher company and leader in life science analytical technologies, introduced platform-wide advancements across its accurate mass ZenoTOF line. The updates include new SCIEX OS 5.0 software features, broader front-end compatibility, and forward-looking software collaborations designed to help omics researchers solve complex biological questions. This connected environment reduces workflow complexity, while enabling deeper, more actionable insights from a single, dynamic platform. SCIEX OS 5.0 software introduces new features including Central Metrics Tracker, Central Monitoring, Reporter Template Creator, an AI enabled "helpme" function, and AI enabled Calculated Column
- ANALYSTCitigroup resumed coverage on Danaher with a new price targetCitigroup resumed coverage of Danaher with a rating of Buy and set a new price target of $230.00
- PRHenry Schein Announces the Election of William K. "Dan" Daniel as Independent Chairman of the BoardHenry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today announced that its Board of Directors has elected William K. "Dan" Daniel as Independent Chairman of the Board, effective May 21, 2026. Mr. Daniel succeeds Stanley M. Bergman, who retired from the Board following 44 years as a Director of Henry Schein and was named Chairman Emeritus in recognition of his extraordinary contributions to the Company. Mr. Daniel joined the Henry Schein Board of Directors in May 2025. He possesses decades of board and global executive leadership experience in healthcare and industrial sectors, including serving for 14
- INSIDERSVP, Human Resources Couchara Georgeann covered exercise/tax liability with 281 shares, decreasing direct ownership by 3% to 8,291 units (SEC Form 4)4 - DANAHER CORP /DE/ (0000313616) (Issuer)
- INSIDERDirector Filler Linda was granted 680 shares, increasing direct ownership by 3% to 24,712 units (SEC Form 4)4 - DANAHER CORP /DE/ (0000313616) (Issuer)
- INSIDERDirector Stevens Raymond C was granted 680 shares, increasing direct ownership by 5% to 13,728 units (SEC Form 4)4 - DANAHER CORP /DE/ (0000313616) (Issuer)
- INSIDERDirector Sanders A Shane was granted 680 shares, increasing direct ownership by 13% to 5,914 units (SEC Form 4)4 - DANAHER CORP /DE/ (0000313616) (Issuer)
- INSIDERDirector Spoon Alan G was granted 680 shares, increasing direct ownership by 0.55% to 124,774 units (SEC Form 4)4 - DANAHER CORP /DE/ (0000313616) (Issuer)
- INSIDERDirector Zerhouni Elias A. was granted 680 shares, increasing direct ownership by 2% to 43,186 units (SEC Form 4)4 - DANAHER CORP /DE/ (0000313616) (Issuer)
- INSIDERDirector List Teri was granted 680 shares, increasing direct ownership by 3% to 21,470 units (SEC Form 4)4 - DANAHER CORP /DE/ (0000313616) (Issuer)
- INSIDERDirector Lamanna Charles W was granted 680 shares, increasing direct ownership by 100% to 1,359 units (SEC Form 4)4 - DANAHER CORP /DE/ (0000313616) (Issuer)
- INSIDERDirector Dewan Feroz was granted 680 shares, increasing direct ownership by 17% to 4,686 units (SEC Form 4)4 - DANAHER CORP /DE/ (0000313616) (Issuer)
- ANALYSTRBC Capital Mkts resumed coverage on Danaher with a new price targetRBC Capital Mkts resumed coverage of Danaher with a rating of Outperform and set a new price target of $200.00
- SECSEC Form SD filed by Danaher CorporationSD - DANAHER CORP /DE/ (0000313616) (Filer)
- SECDanaher Corporation filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits8-K - DANAHER CORP /DE/ (0000313616) (Filer)
- PRDanaher Announces Quarterly DividendWASHINGTON, May 5, 2026 /PRNewswire/ -- Danaher Corporation (NYSE:DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.40 per share of its common stock, payable on July 31, 2026 to holders of record on June 26, 2026. ABOUT DANAHERDanaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. Through our connected ecosystem of industry-leading businesses, we work side by side with customers to solve many of their most complex scientific and clinical challenges—helping move innovations from discovery to delivery faster for patients who depend on them.Pow
- INSIDERDirector Spoon Alan G exercised 3,298 shares at a strike of $71.88 and sold $237,207 worth of shares (1,358 units at $174.67), increasing direct ownership by 2% to 124,094 units (SEC Form 4)4 - DANAHER CORP /DE/ (0000313616) (Issuer)
- PRMasimo Shareholders Approve Acquisition by DanaherMasimo Corporation (NASDAQ:MASI) ("Masimo"), a leading global innovator in patient monitoring, today announced that its stockholders voted in favor of the proposal to adopt the previously announced Agreement and Plan of Merger, dated February 16, 2026 (the "Merger Agreement"), by and among Masimo, Danaher Corporation ("Danaher") (NYSE:DHR) and Mobius Merger Sub, Inc. (the "Merger Sub") at Masimo's special meeting of stockholders held virtually on May 1, 2026 (the "Special Meeting"). Katie Szyman, Chief Executive Officer of Masimo, stated: "We thank our shareholders for their strong support of this important milestone for Masimo. The Merger delivers compelling value and positions Masimo fo
- SECSEC Form CERT filed by Danaher CorporationCERT - DANAHER CORP /DE/ (0000313616) (Filer)
- SECSEC Form 8-A12B filed by Danaher Corporation8-A12B - DANAHER CORP /DE/ (0000313616) (Filer)
- SECSEC Form 8-K filed by Danaher Corporation8-K - DANAHER CORP /DE/ (0000313616) (Filer)
DHR FAQ
6 questionsWhat does Danaher Corporation do?
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and...Where does DHR stock trade?
Danaher Corporation (DHR) is listed on NYSE.What sector and industry is DHR in?
Danaher Corporation operates in the Industrials sector, Industrial Machinery/Components industry.What are analysts saying about DHR?
Danaher Corporation has had 8 recent analyst actions on file. The most recent action was from DZ Bank: Buy on 2026-06-03.What companies are similar to DHR?
Notable peers in the same industry include ASML (ASML Holding N.V. New York Registry Shares), LRCX (Lam Research Corporation), TMO (Thermo Fisher Scientific Inc), DE (Deere & Company), ETN (Eaton Corporation PLC). Compare DHR side-by-side with any of them on Quantisnow.How can I track DHR on Quantisnow?
Quantisnow aggregates Danaher Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow DHR to receive live email and push alerts on every new disclosure.